NCT05095337

Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male Volunteers

A Phase I Mass Balance and Biotransformation Study of [14C]SHR1459 in Chinese Healthy Adult Male Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Evaluate the Mass Balance and Biotransformation of \[14C\]SHR1459 in Healthy Adult Male Volunteers

Conditions

• Healthy Adult Male Volunteers

Interventions

Type	Name	Description
DRUG	[14C]SHR1459	Patients will receive single dose of orally \[14C\]SHR1459 on Day 1.

Timeline

• Start date: 2022-06-07
• Primary completion: 2022-07-05
• Completion: 2022-07-25
• First posted: 2021-10-27
• Last updated: 2022-07-01

Locations

1 site across 1 country: China